Prev：Generation and Application of Monoclonal Antibodies against Porcine S100A8, S100A9, and S100A12 Proteins Using Hybridoma Technology(A23210-6)
Next：Generation and characterization of iPSCs from a patient with obsessive–compulsive disorder, his mother with schizophrenia and his healthy father(A23210-1)
